Cargando…
Liver Transplantation Is Highly Effective in Children with Irresectable Hepatoblastoma
Background and Objectives: In children, hepatoblastoma preferentially is managed by liver resection (LR). However, in irresectable cases, liver transplantation (LT) is required. The aim of our study was to compare short- and long-term results after LR and LT for the curative treatment of hepatoblast...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399470/ https://www.ncbi.nlm.nih.gov/pubmed/34441025 http://dx.doi.org/10.3390/medicina57080819 |
_version_ | 1783745083906981888 |
---|---|
author | Moosburner, Simon Schmelzle, Moritz Schöning, Wenzel Kästner, Anika Seika, Philippa Globke, Brigitta Dziodzio, Tomasz Pratschke, Johann Öllinger, Robert Gül-Klein, Safak |
author_facet | Moosburner, Simon Schmelzle, Moritz Schöning, Wenzel Kästner, Anika Seika, Philippa Globke, Brigitta Dziodzio, Tomasz Pratschke, Johann Öllinger, Robert Gül-Klein, Safak |
author_sort | Moosburner, Simon |
collection | PubMed |
description | Background and Objectives: In children, hepatoblastoma preferentially is managed by liver resection (LR). However, in irresectable cases, liver transplantation (LT) is required. The aim of our study was to compare short- and long-term results after LR and LT for the curative treatment of hepatoblastoma. Materials and Methods: Retrospective analysis of all patients treated surgically for hepatoblastoma from January 2000 until December 2019 was performed. Demographic and clinical data were collected before and after surgery. The primary endpoints were disease free survival and patient survival. Results: In total, 38 patients were included into our analysis (n = 28 for LR, n = 10 for LT) with a median follow-up of 5 years. 36 patients received chemotherapy prior to surgery. Total hospital stay and intensive care unit (ICU) stay were significantly longer within the LT vs. the LR group (ICU 23 vs. 4 days, hospital stay 34 vs. 16 days, respectively; p < 0.001). Surgical complications (≤Clavien–Dindo 3a) were equally distributed in both groups (60% vs. 57%; p = 1.00). Severe complications (≥Clavien–Dindo 3a) were more frequent after LT (50% vs. 21.4%; p = 0.11). Recurrence rates were 10.7% for LR and 0% for LT at 5 years after resection or transplantation (p = 0.94). Overall, 5-year survival was 90% for LT and 96% for LR (p = 0.44). Conclusions: In irresectable cases, liver transplantation reveals excellent outcomes in children with hepatoblastoma with an acceptable number of perioperative complications. |
format | Online Article Text |
id | pubmed-8399470 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83994702021-08-29 Liver Transplantation Is Highly Effective in Children with Irresectable Hepatoblastoma Moosburner, Simon Schmelzle, Moritz Schöning, Wenzel Kästner, Anika Seika, Philippa Globke, Brigitta Dziodzio, Tomasz Pratschke, Johann Öllinger, Robert Gül-Klein, Safak Medicina (Kaunas) Article Background and Objectives: In children, hepatoblastoma preferentially is managed by liver resection (LR). However, in irresectable cases, liver transplantation (LT) is required. The aim of our study was to compare short- and long-term results after LR and LT for the curative treatment of hepatoblastoma. Materials and Methods: Retrospective analysis of all patients treated surgically for hepatoblastoma from January 2000 until December 2019 was performed. Demographic and clinical data were collected before and after surgery. The primary endpoints were disease free survival and patient survival. Results: In total, 38 patients were included into our analysis (n = 28 for LR, n = 10 for LT) with a median follow-up of 5 years. 36 patients received chemotherapy prior to surgery. Total hospital stay and intensive care unit (ICU) stay were significantly longer within the LT vs. the LR group (ICU 23 vs. 4 days, hospital stay 34 vs. 16 days, respectively; p < 0.001). Surgical complications (≤Clavien–Dindo 3a) were equally distributed in both groups (60% vs. 57%; p = 1.00). Severe complications (≥Clavien–Dindo 3a) were more frequent after LT (50% vs. 21.4%; p = 0.11). Recurrence rates were 10.7% for LR and 0% for LT at 5 years after resection or transplantation (p = 0.94). Overall, 5-year survival was 90% for LT and 96% for LR (p = 0.44). Conclusions: In irresectable cases, liver transplantation reveals excellent outcomes in children with hepatoblastoma with an acceptable number of perioperative complications. MDPI 2021-08-12 /pmc/articles/PMC8399470/ /pubmed/34441025 http://dx.doi.org/10.3390/medicina57080819 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Moosburner, Simon Schmelzle, Moritz Schöning, Wenzel Kästner, Anika Seika, Philippa Globke, Brigitta Dziodzio, Tomasz Pratschke, Johann Öllinger, Robert Gül-Klein, Safak Liver Transplantation Is Highly Effective in Children with Irresectable Hepatoblastoma |
title | Liver Transplantation Is Highly Effective in Children with Irresectable Hepatoblastoma |
title_full | Liver Transplantation Is Highly Effective in Children with Irresectable Hepatoblastoma |
title_fullStr | Liver Transplantation Is Highly Effective in Children with Irresectable Hepatoblastoma |
title_full_unstemmed | Liver Transplantation Is Highly Effective in Children with Irresectable Hepatoblastoma |
title_short | Liver Transplantation Is Highly Effective in Children with Irresectable Hepatoblastoma |
title_sort | liver transplantation is highly effective in children with irresectable hepatoblastoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399470/ https://www.ncbi.nlm.nih.gov/pubmed/34441025 http://dx.doi.org/10.3390/medicina57080819 |
work_keys_str_mv | AT moosburnersimon livertransplantationishighlyeffectiveinchildrenwithirresectablehepatoblastoma AT schmelzlemoritz livertransplantationishighlyeffectiveinchildrenwithirresectablehepatoblastoma AT schoningwenzel livertransplantationishighlyeffectiveinchildrenwithirresectablehepatoblastoma AT kastneranika livertransplantationishighlyeffectiveinchildrenwithirresectablehepatoblastoma AT seikaphilippa livertransplantationishighlyeffectiveinchildrenwithirresectablehepatoblastoma AT globkebrigitta livertransplantationishighlyeffectiveinchildrenwithirresectablehepatoblastoma AT dziodziotomasz livertransplantationishighlyeffectiveinchildrenwithirresectablehepatoblastoma AT pratschkejohann livertransplantationishighlyeffectiveinchildrenwithirresectablehepatoblastoma AT ollingerrobert livertransplantationishighlyeffectiveinchildrenwithirresectablehepatoblastoma AT gulkleinsafak livertransplantationishighlyeffectiveinchildrenwithirresectablehepatoblastoma |